Getting to the After Times: CF and COVID in Year 2 - Richard Moss, MD

Dr. Rick Moss, Professor Emeritus of Pediatrics at Stanford University and retired Director of the Stanford Cystic Fibrosis Center, gives an update on key aspects of the pandemic currently relevant to CF: vulnerability to COVID in the CF community, transmission, vaccine availability and safety, breakthrough infections, variants, special issues for the immunocompromised, and more. Dr. Moss reviews current evidence and recommendations, and gives a global outlook. This presentation was part of CFRI's Virtual 34th National CF Education Conference on July 31, 2021.

CFRI's 34th National CF Education Conference was sponsored by Vertex Pharmaceuticals, Genentech, Gilead Sciences, Chiesi USA, AbbVie, and Ionis Pharmaceuticals.